Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Detalles Bibliográficos
Autores principales: Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D
Formato: Conference item
Publicado: 2009

Ejemplares similares